Novel Dry Powder Inhalers: Newer dry powder inhaler (DPI) technologies under Inhalable Drugs are improving the delivery and reproducibility of inhaled drug doses. DPIs that use capsules or blister foils to contain the drug powder offer advantages over older devices in terms of stability and dosing consistency. Several major pharmaceutical companies have received approvals for novel asthma and COPD medications delivered via improved DPI formulations.

Pulmonary Drug Delivery Technologies: Areas like 3D printing of inhalable polymeric structures hold promise for enhancing drug loading and controlling release in the lungs. Nanoparticles, lipid vesicles and other advanced carrier systems are also being researched to optimize deposition and absorption of new classes of biologic drugs.

Get more insights on Global Inhalable Drugs

Also Read Related Article on m-RNA Synthesis Service